Functional Food Lipidomics: Bioavailability & Precision Nutrition

Lipidomics Solutions for Functional Foods and Precision Nutrition

Creative Proteomics provides specialized functional food lipidomics and high-resolution metabolic profiling to quantify the bioavailability of functional lipids and validate dietary efficiency. Utilizing LC-MS/MS platforms, we empower R&D teams to substantiate product claims, map systemic metabolic responses, and optimize the bio-efficacy of next-generation precision nutrition interventions.

Key capabilities

  • Absolute Bioavailability Quantification: Precise measurement of fatty acid incorporation into plasma and erythrocyte membranes using stable isotope dilution.
  • Nutritional Phenotyping: Comprehensive mapping of individual metabolic responses to dietary interventions to identify "responders" vs. "non-responders."
  • Postprandial Hemodynamics: Dynamic tracking of lipid remodeling and metabolic clearance rates through high-frequency sampling workflows.
Request a Quote

Submit Your Request Now

×

Our services have earned the trust of companies, schools, and organizations globally, and we remain dedicated to maintaining that trust.

Boston University
University at Buffalo
UMass Medical School
Hawaii Pacific University
Medizinische Fakultät
Louisiana State University
Nyulangone
Nature's Fynd
Dietary Supplement Manufacturer
  • Trends
  • Solution Matrix
  • Technical Advantages
  • Case Studies
  • FAQ

Situational Solution Matrix for Functional Food & Precision Nutrition

Functional food development and precision nutrition studies often progress from discovery screening to targeted confirmation and then pathway-focused interpretation.

Omega-3 Absorption vs Formulation Debate

Situation

Teams observe inconsistent DHA/EPA plasma increases across products and suspect phospholipid (PL) vs. triglyceride (TG) dose-form differences.

Goal

Quantify Omega-3 absorption lipidomics with time-resolved incorporation signals and structural confirmation.

Recommended path

Bundle A → Bundle B → Bundle C

What you will get

Dose-form comparable fatty acid readouts and absorption kinetics (Cmax, AUC) to substantiate superior delivery claims.

Postprandial Lipid Kinetics for Dietary Intervention Readout

Situation

A nutrition intervention study needs objective response markers beyond questionnaires and fasting lipid panels after ingesting MCTs or functional emulsions.

Goal

Track dynamic lipid monitoring to quantify intervention-driven lipid remodeling and mitochondrial beta-oxidation.

Recommended path

Bundle A → Bundle B → Bundle C

What you will get

Time-course lipid signatures, validated markers, and beta-oxidation–related acylcarnitine patterns for mechanistic interpretation.

Human Milk vs Formula Lipid Composition Benchmarking

Situation

R&D teams are engineering premium "breast-milk-mimetic" formulas and need to benchmark their lipid composition against human milk prototypes.

Goal

Compare lipid classes, polar lipids, and SN-positional isomers to guide formulation alignment.

Recommended path

Bundle A → Bundle B

What you will get

Compositional comparability across complex lipid classes and structural similarity scores suitable for prototype ranking.

Inflammation-Adjacent Functional Lipid Mediator Profiling

Situation

A functional ingredient appears to influence signaling pathways associated with lipid mediators and systemic inflammation.

Goal

Quantify pro-resolving and pro-inflammatory oxylipin and eicosanoid pathways with isomer-aware targeted panels.

Recommended path

Bundle B → Bundle C

What you will get

COX/LOX/CYP pathway-aligned mediator quantification connecting dietary interventions directly to lipid signaling responses.

Sterol Pathway Shifts Under Diet or Fortification

Situation

Diet composition or functional foods fortified with plant sterols/stanols may alter cholesterol biosynthesis or oxidative stress.

Goal

Map cholesterol intermediates and oxysterols as pathway-level readouts to evaluate cardiovascular and metabolic efficacy.

Recommended path

Bundle B → Bundle C

What you will get

Comprehensive sterol pathway profiles supporting mechanistic interpretation of diet-driven cholesterol lowering and lipid metabolism changes.

Bioavailability of Polar Lipids Claim Substantiation

Situation

Stakeholders request evidence supporting the bioavailability of polar lipids while stratifying clinical trial subjects based on baseline lipidomes.

Goal

Generate RUO bioavailability evidence with kinetic sampling and unbiased mapping of the plasma lipidome to discover robust dietary lipid biomarkers.

Recommended path

Bundle A → Bundle B

What you will get

Broad lipid class shifts and multivariate predictive models establishing objective diet-response readouts across different cohorts.

Selected Case Studies in Nutritional Science

Source: Wang et al., 2024, Nature Medicine. https://doi.org/10.1038/s41591-024-03124-1

Diet Fat Quality Signatures for Precision Nutrition Lipidomics

Who needs this

Nutrition R&D and translational teams designing intervention endpoints beyond self-reported intake.

Method used

Controlled dietary fat substitution trial data used to generate a lipidome score and test associations across cohorts.

Result obtained

A lipidome-derived score captured diet-driven lipid shifts and linked them to cardiometabolic risk associations (RUO evidence for objective diet-response readouts).

Recommended path: Bundle A → Bundle B → Bundle C

Study design figure for precision nutrition lipidomics linking diet fat quality to lipidome response.
Fig. 1 | Study design. Study design enabling precision nutrition lipidomics scoring from controlled dietary fat substitution.
Source: Papanikolaou et al., 2022, Foods. https://doi.org/10.3390/foods11213404

Dairy/Egg Lipid Composition Benchmarking

Who needs this

Functional food teams benchmarking omega-3 fatty acid analysis outputs across animal-derived matrices and product variants.

Method used

Food matrix lipid composition quantified (GC-MS/GC-FID style fatty acid profiling) to compare omega-3/omega-6 distributions across groups.

Result obtained

Matrix and feed conditions shifted omega-3 content and omega-6:omega-3 ratio, reinforcing the need to measure composition before claiming bioavailability.

Recommended path: Bundle A → Bundle B

Table of egg yolk fatty acids used for omega-3 fatty acid analysis and functional food lipidomics profiling.
Table 5. Fatty acid profile of the egg yolks (% of total fatty acids). Fatty acid profile table supporting functional food lipidomics profiling and omega-3 fatty acid analysis comparisons.
Source: Couëdelo, L., et al., 2024, Nutrients. https://doi.org/10.3390/nu16071014

Lymph Kinetics and Omega-3 Absorption Lipidomics

Who needs this

Formulation and ingredient teams comparing omega-3 vectors (EE, TG, MG, emulsions, phospholipid blends) for absorption claims (RUO).

Method used

Rat lymphatic duct fistula model with 6-hour postprandial kinetics; DHA delivered in different molecular/supramolecular carriers; lipid fractions quantified over time.

Result obtained

DHA absorption kinetics and distribution into lymph lipid fractions varied by carrier form, demonstrating why bioavailability of polar lipids needs time-course evidence rather than static endpoints.

Recommended path: Bundle A → Bundle B → Bundle C

Figure of lymph lipid fractions for omega-3 absorption lipidomics, informing bioavailability of polar lipids vs neutral lipids.
Figure 3. Characterization of lymph lipids in terms of lipid fractions at 6 h after lipid administration. Lymph lipid fractions after omega-3 dosing support omega-3 absorption lipidomics and bioavailability of polar lipids evaluation.

Frequently Asked Questions

How do you distinguish between endogenously synthesized lipids and dietary lipid intake?
We utilize high-resolution mass spectrometry to track specific fatty acid "signatures" (such as odd-chain or branched-chain fatty acids) and specific positional isomers that are unique to certain dietary functional oils, providing a biochemical footprint of exogenous intake.
What is the ideal sampling timeline for a postprandial bioavailability study?
For most functional oils, we recommend a baseline sample (T0) followed by frequent sampling at 1, 2, 4, 6, 8, and 24 hours post-intake to capture the complete Tmax and Cmax curves during postprandial lipid monitoring.
Can lipidomics separate SN-1/3 vs SN-2 positional isomers in functional oils?
Yes. Through specialized lipase digestion followed by high-resolution chiral chromatography, we can determine the exact distribution of fatty acids on the glycerol backbone, which is crucial for infant formula "mimetic" validation.
How do you prevent auto-oxidation of Omega-3 samples during extraction?
We employ a strict oxygen-depleted extraction environment at 4°C, augmented with BHT and EDTA antioxidants to halt any ex vivo peroxidation of highly unsaturated functional lipids immediately upon sample thawing.
What biological matrices are recommended for precision nutrition?
While plasma or serum provides a snapshot of recent intake, we also recommend erythrocyte (red blood cell) membrane analysis for long-term (120-day) bioavailability tracking, and fecal samples for gut-microbiome-lipid axis studies.
Can you analyze the lipidomic profile of microencapsulated or emulsified functional lipids?
Absolutely. We have developed specialized "release-and-extract" protocols to quantify the lipid load and fatty acid integrity within various food delivery matrices, ensuring the protective coating does not interfere with mass spectrometry detection.
How does lipidomics support "Clean Label" claims in the food industry?
By detecting trace environmental contaminants and processing-induced oxidation markers (oxylipins), we provide the scientific evidence needed to verify the purity, stability, and natural integrity of functional ingredients.
Do you provide subject stratification services for clinical dietary trials?
Yes. Our bioinformatics team uses advanced multivariate statistics (PCA, OPLS-DA) to cluster clinical trial participants based on their baseline and post-intervention lipidomes, identifying metabolic sub-types and intervention "responders."
* Our services can only be used for research purposes and Not for clinical use.

Applications:


Online Inquiry

CONTACT US

Copyright © 2026 Creative Proteomics. All rights reserved.